ClinicalTrials.gov
public full text
Public Domain
Study Evaluating Single and Repeated Intravitreal Doses of ICON-1 in Patients With Uveal Melanoma
The purpose of this study is to evaluate the safety, tolerability, biological activity, pharmacokinetics and pharmacodynamic activity of single and repeated escalating intravitreal doses of ICON-1 in patients with primary uveal melanoma who are planned to undergo enucleation or brachytherapy of the affected eye.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Prospective Study of Ingenol Mebutate for Non-invasive Lentigo Melanoma of the Face#1047357
- Role of Intravitreal Aflibercept Injection for the Treatment of Radiation Maculopathy#861453
- A Dose Escalation Study of IBI333 in Subjects With Neovascular Age-related Macular Degeneration#1152517
- Pharmacokinetic and Tolerance Study of Meloxicam Eye Drops in Healthy Volunteers#1009064
- Definity for Ultrasound of Intraocular Tumors#863137
Record · ID 1436688
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive